Project Description

NanoPass Technologies is a pioneer in the field of intradermal delivery of vaccines and large molecules (e.g. insulin). NanoPass Technologies developed MicronJetTM, a silicon-based micro-needle, the first and currently the only true intradermal (skin) delivery solution being commercialized for vaccines and large molecules.